Connecting life science corporates with capital as part of Europe's biggest healthcare-dedicated investment week
Defn: investival showcase
4th Annual Inv€$tival Showcase
What is it and who is it for?
Returning for its fourth year, LSX’s Investival Showcase continues and expands upon its exclusive partnership with global investment bank Jefferies, with the showcase co-located with the Jefferies 2019 London Healthcare Conference.
The Investival Showcase directly connects life sciences corporates to global capital.
A multi-streamed showcase of early, growth stage and public life science and health technology companies, Investival Showcase offers the opportunity for a greater proportion of private and smaller cap public companies to be a part of the biggest week in European life sciences investment. It provides the opportunity to pitch, profile and connect with investment partners brought together in London by both LSX, and Jefferies.
Over the last three years, Investival Showcase has welcomed numerous companies across all areas of biotech, medtech and healthtech who have been looking to raise their capital and profile amongst investors. We'd like to talk to all companies about the options available for joining the event and the showcase but our investor network are always particularly interested in innovations in oncology, neurology, infectious diseases, immunology, cardiovascular, musculoskeletal, respiratory, cardiometabolic, as well as medtech and healthtech in all areas.
Managing Partner, Kurma Partners
Managing Partner, Inkef Capital
Head of Europe, Sanofi Ventures
Managing Partner, Wellington Partners
Co-Chair, Securities & Capital Markets Practice, Mintz
Britt Meelby Jensen CEO, Atos Medical
CEO, Immatics Biotechnology
CFO, HOOKIPA Pharma
Chair, Securities & Capital Markets Practice, Mintz